FindTrial
Sign In

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Dopamine Reuptake Inhibitors of Cocaine Abuse

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000276
Enrollment
0
Registered
1999-09-21
Start date
1994-09-30
Completion date
1999-08-31
Last updated
2020-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

Cocaine-Related Disorders

Brief summary

The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.

Interventions

DRUGBupropion

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
VA Connecticut Healthcare System
CollaboratorFED
Yale University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

\-

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Side effects—
Cocaine effects—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026